SCHEMBL4160691

SCHEMBL4160691

O=c1c(O)c(-c2ccc(OCc3ccccc3)c(OCc3ccccc3)c2)oc2cc(OCCOCc3ccccc3)ccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.54
TP53 P04637 5/20 0.54
RXFP1 Q9HBX9 2/20 0.54
ABCG2 Q9UNQ0 9/20 0.53
ABCB1 P08183 6/20 0.48
ABCC1 P33527 5/20 0.48
KDM4E B2RXH2 4/20 0.47
MEN1 O00255 4/20 0.47
CYP3A4 P08684 4/20 0.47
CASP1 P29466 4/20 0.47
CASP7 P55210 4/20 0.47
KMT2A Q03164 4/20 0.47
HSD17B10 Q99714 4/20 0.47
ALDH1A1 P00352 3/20 0.47
HPGD P15428 3/20 0.47
LMNA P02545 2/20 0.47
ALOX15 P16050 2/20 0.47
ADORA3 P0DMS8 1/20 0.46
MAPK1 P28482 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4164670 0.92 MAPT (0.60) MAPTTP53RXFP1ABCG2ABCB1
SCHEMBL1180406 0.86 ABCG2 (0.57) MAPTTP53RXFP1ABCG2ABCB1
SCHEMBL4160690 0.85 MAPT (0.52) MAPTTP53RXFP1ABCG2ABCB1
SCHEMBL2397393 0.84 MAPT (0.75) MAPTTP53RXFP1ABCG2ABCB1
SCHEMBL25022832 0.83 ABCG2 (0.73) MAPTTP53RXFP1ABCG2ABCB1
SCHEMBL20169884 0.83 CYP3A4 (0.61) MAPTTP53ABCG2ABCB1KDM4E
SCHEMBL27491848 0.81 KDM4E (0.66) MAPTTP53ABCB1KDM4EMEN1
SCHEMBL31031167 0.81 AR (0.58) MAPTTP53RXFP1ABCG2ABCB1
SCHEMBL4150944 0.81 MAOB (0.51) MAPTTP53RXFP1ABCG2ABCB1
SCHEMBL12722554 0.79 MAPT (0.56) MAPTTP53RXFP1ABCG2ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090130051-A1 Flavonoid Compounds and Uses Thereof HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) 2009-05-21 US claimed
US-20020147353-A1 Novel flavonoids VERENIGING CHRISTELIJK WETENSCHAPPELIJK ANDERWIJS (NL) 2002-10-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020147353-A1 Novel flavonoids H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR1, ABCC8 MAPT 4588/4885TP53 730/4885RXFP1 1293/4885
US-20090130051-A1 Flavonoid Compounds and Uses Thereof CAT, NQO1, GPX4 MAPT 3887/4885TP53 1834/4885RXFP1 2880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.